Statens investering i kliniske forsøg

Sofie Louise Rygård; Maj-Brit Nørregaard Kjær; Anders Perner

Statens investering i kliniske forsøg

Sofie Louise Rygård, Maj-Brit Nørregaard Kjær, Anders Perner

Institut for Klinisk Medicin

Abstract

Clinical trials are important to ensure that patients and society benefit from healthcare interventions. Among the Danish public research investments in medical sciences the main part of funding is given to preclinical and translational research, and less than ten per cent is given to clinical trials. This imbalance may have negative consequences for patients and society, because public investment in clinical trials is likely to ensure broader availability of tested interventions independent of diseases, patient groups, caregivers and clinical settings.

Bidragets oversatte titel	Danish public research investments in clinical trials
Originalsprog	Dansk
Artikelnummer	V09170645
Tidsskrift	Ugeskrift for Laeger
Vol/bind	180
Udgave nummer	26
Antal sider	3
ISSN	0041-5782
Status	Udgivet - 2018

Adgang til dokumentet

http://ugeskriftet.dk/videnskab/statens-investering-i-kliniske-forsoeg

Citationsformater

@article{4851eb2571db44869abdb528ed00e8ac,

title = "Statens investering i kliniske fors{\o}g",

abstract = "Clinical trials are important to ensure that patients and society benefit from healthcare interventions. Among the Danish public research investments in medical sciences the main part of funding is given to preclinical and translational research, and less than ten per cent is given to clinical trials. This imbalance may have negative consequences for patients and society, because public investment in clinical trials is likely to ensure broader availability of tested interventions independent of diseases, patient groups, caregivers and clinical settings.",

author = "Ryg{\aa}rd, {Sofie Louise} and Kj{\ae}r, {Maj-Brit N{\o}rregaard} and Anders Perner",

year = "2018",

language = "Dansk",

volume = "180",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

number = "26",

}

TY - JOUR

T1 - Statens investering i kliniske forsøg

AU - Rygård, Sofie Louise

AU - Kjær, Maj-Brit Nørregaard

AU - Perner, Anders

PY - 2018

Y1 - 2018

N2 - Clinical trials are important to ensure that patients and society benefit from healthcare interventions. Among the Danish public research investments in medical sciences the main part of funding is given to preclinical and translational research, and less than ten per cent is given to clinical trials. This imbalance may have negative consequences for patients and society, because public investment in clinical trials is likely to ensure broader availability of tested interventions independent of diseases, patient groups, caregivers and clinical settings.

AB - Clinical trials are important to ensure that patients and society benefit from healthcare interventions. Among the Danish public research investments in medical sciences the main part of funding is given to preclinical and translational research, and less than ten per cent is given to clinical trials. This imbalance may have negative consequences for patients and society, because public investment in clinical trials is likely to ensure broader availability of tested interventions independent of diseases, patient groups, caregivers and clinical settings.

M3 - Tidsskriftartikel

C2 - 29938641

SN - 0041-5782

VL - 180

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 26

M1 - V09170645

ER -

Statens investering i kliniske forsøg

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater